193 related articles for article (PubMed ID: 28858133)
1. Kallmann syndrome with a Tyr113His PROKR2 mutation.
Ha JH; Lee S; Kim Y; Moon JI; Seo J; Jang JH; Cho EH; Kim JM; Rhee BD; Ko KS; Yoo SJ; Won JC
Medicine (Baltimore); 2017 Sep; 96(35):e7974. PubMed ID: 28858133
[TBL] [Abstract][Full Text] [Related]
2. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
[TBL] [Abstract][Full Text] [Related]
3. Eight rare urinary disorders in a patient with Kallmann syndrome: A case report.
Tian H; Yan Z; Lv Y; Sun L; Gang X; Wang G
Medicine (Baltimore); 2020 Oct; 99(43):e22936. PubMed ID: 33120852
[TBL] [Abstract][Full Text] [Related]
4. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
Cole LW; Sidis Y; Zhang C; Quinton R; Plummer L; Pignatelli D; Hughes VA; Dwyer AA; Raivio T; Hayes FJ; Seminara SB; Huot C; Alos N; Speiser P; Takeshita A; Van Vliet G; Pearce S; Crowley WF; Zhou QY; Pitteloud N
J Clin Endocrinol Metab; 2008 Sep; 93(9):3551-9. PubMed ID: 18559922
[TBL] [Abstract][Full Text] [Related]
5. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
Dodé C; Teixeira L; Levilliers J; Fouveaut C; Bouchard P; Kottler ML; Lespinasse J; Lienhardt-Roussie A; Mathieu M; Moerman A; Morgan G; Murat A; Toublanc JE; Wolczynski S; Delpech M; Petit C; Young J; Hardelin JP
PLoS Genet; 2006 Oct; 2(10):e175. PubMed ID: 17054399
[TBL] [Abstract][Full Text] [Related]
6. PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity.
Monnier C; Dodé C; Fabre L; Teixeira L; Labesse G; Pin JP; Hardelin JP; Rondard P
Hum Mol Genet; 2009 Jan; 18(1):75-81. PubMed ID: 18826963
[TBL] [Abstract][Full Text] [Related]
7. Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.
Gu WJ; Zhang Q; Wang YQ; Yang GQ; Hong TP; Zhu DL; Yang JK; Ning G; Jin N; Chen K; Zang L; Wang AP; Du J; Wang XL; Yang LJ; Ba JM; Lv ZH; Dou JT; Mu YM
Exp Biol Med (Maywood); 2015 Nov; 240(11):1480-9. PubMed ID: 26031747
[TBL] [Abstract][Full Text] [Related]
8. PROKR2 mutations in autosomal recessive Kallmann syndrome.
Tommiska J; Toppari J; Vaaralahti K; Känsäkoski J; Laitinen EM; Noisa P; Kinnala A; Niinikoski H; Raivio T
Fertil Steril; 2013 Mar; 99(3):815-8. PubMed ID: 23200691
[TBL] [Abstract][Full Text] [Related]
9. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.
Sarfati J; Dodé C; Young J
Front Horm Res; 2010; 39():121-132. PubMed ID: 20389090
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
[TBL] [Abstract][Full Text] [Related]
11. Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients.
Sarfati J; Fouveaut C; Leroy C; Jeanpierre M; Hardelin JP; Dodé C
Eur J Endocrinol; 2013 Dec; 169(6):805-9. PubMed ID: 24031091
[TBL] [Abstract][Full Text] [Related]
12. Identification of MMACHC and PROKR2 mutations causing coexistent cobalamin C disease and Kallmann syndrome in a young woman.
Yuan H; Deng S; Gao W; Li H; Yuan M
Metab Brain Dis; 2021 Mar; 36(3):447-452. PubMed ID: 33411215
[TBL] [Abstract][Full Text] [Related]
13. Additional mutation in
Ichioka K; Yoshikawa T; Kimura H; Saito R
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38272512
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and genotypic landscape of PROKR2 in neuroendocrine disorders.
Martinez-Mayer J; Perez-Millan MI
Front Endocrinol (Lausanne); 2023; 14():1132787. PubMed ID: 36843573
[TBL] [Abstract][Full Text] [Related]
15. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
Hardelin JP; Dodé C
Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
[TBL] [Abstract][Full Text] [Related]
16. Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia.
McCabe MJ; Gaston-Massuet C; Gregory LC; Alatzoglou KS; Tziaferi V; Sbai O; Rondard P; Masumoto KH; Nagano M; Shigeyoshi Y; Pfeifer M; Hulse T; Buchanan CR; Pitteloud N; Martinez-Barbera JP; Dattani MT
J Clin Endocrinol Metab; 2013 Mar; 98(3):E547-57. PubMed ID: 23386640
[TBL] [Abstract][Full Text] [Related]
17. Identification of two novel missense mutations in the KAL1 gene in Han Chinese subjects with Kallmann Syndrome.
Jap TS; Chiu CY; Lirng JF; Won GS
J Endocrinol Invest; 2011 Jan; 34(1):53-9. PubMed ID: 20530987
[TBL] [Abstract][Full Text] [Related]
18. Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome.
Barraud S; Delemer B; Poirsier-Violle C; Bouligand J; Mérol JC; Grange F; Higel-Chaufour B; Decoudier B; Zalzali M; Dwyer AA; Acierno JS; Pitteloud N; Millar RP; Young J
Neuroendocrinology; 2021; 111(1-2):99-114. PubMed ID: 32074614
[TBL] [Abstract][Full Text] [Related]
19. PROKR2 and PROK2 mutations cause isolated congenital anosmia without gonadotropic deficiency.
Moya-Plana A; Villanueva C; Laccourreye O; Bonfils P; de Roux N
Eur J Endocrinol; 2013 Jan; 168(1):31-7. PubMed ID: 23082007
[TBL] [Abstract][Full Text] [Related]
20. Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report.
Sinisi AA; Asci R; Bellastella G; Maione L; Esposito D; Elefante A; De Bellis A; Bellastella A; Iolascon A
Hum Reprod; 2008 Oct; 23(10):2380-4. PubMed ID: 18596028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
